AI assistant
ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2023
Jan 27, 2023
33882_dirs_2023-01-27_d73fe227-004f-4620-9dbb-b41a89c2c724.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ACHIEVE LIFE SCIENCES, INC. (ACHV)
CIK: 0000949858
Period of Report: 2023-01-25
Reporting Person: Bencich John (Director, CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-01-25 | Performance Restricted Stock Unit (PRSU) | $ | A | 100000 | Acquired | 2025-12-31 | Common Stock (100000) | Direct |
| 2023-01-25 | Stock Option (right to buy) | $4.90 | A | 100000 | Acquired | 2033-01-25 | Common Stock (100000) | Direct |
Footnotes
F1: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement.
F2: Pursuant to the terms of the award agreement governing the PRSU, the number of underlying shares of the Issuers common stock that may ultimately vest range from 0% to 100% of the number of PRSUs initially granted, subject to certain milestones being met during the measurement period that begins on January 3, 2023 and ends on December 31, 2025.
F3: The options vest one-third on the first anniversary of January 25, 2023 and thereafter in monthly installments over 24 months.